Monitoring incom- plete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth 2013;27:853 8. 85. Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagu- lation tests and heparin assays. J Cardiothorac Vasc Anesth 1997;11:24 8. 86. Guo Y, Tang J, Du L, et al. Protamine dosage based on two titrations reduces blood loss after valve replacement sur- gery: a prospective, double-blinded, randomized study. Can J Cardiol 2012;28:547 52. 87. Shigeta O, Kojima H, Hiramatsu Y, et al. Low-dose prot- amine based on heparin-protamine titration method re- duces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999;118:354 60. 88. Runge M, Moller CH, Steinbruchel DA. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study. J Extra Corpor Technol 2009;41:10 4. 89. Shore-Lesserson L, Reich DL, DePerio M. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Can J Anaesth 1998;45:10 8. 90. Gundry SR, Drongowski RA, Coran AG, Kirsh MM, Klein MD. Failure of automated protamine titration to determine the protamine reversal dose of systemic heparin: comparison with other methods. Curr Surg 1986;43:110 2. 91. Wang J, Ma HP, Zheng H. Blood loss after cardiopulmonary bypass, standard versus titrated protamine: a meta-analysis. Neth J Med 2013;71:123 7. 92. Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery. J Cardiothorac Vasc Anesth 2014;28:235 41. 93. 